BridgeMD
New treatment option for Diabetes in Pregnancy
Official title Effects of Moderate Carbohydrate Consumption on Metabolic and Obstetric Outcomes in Pregnant Women With Insulin-treated Diabetes- A Randomized Controlled Trial
ClinicalTrials.gov ID: NCT06355154
What this study is testing
- What it's testing
- Diabetes during pregnancy increases maternal and fetal complications, necessitating optimal glycemic control. The standard care diet (SCD, ≥175g/day carbohydrate) lacks robust evidence, particularly for pregnancies requiring intensive insulin treatment (IIT).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 45, women only
You may be able to join if
- Pregnant women with singleton pregnancies.
- Over 18 years old.
- Diagnosis of GDM- 3-h 100-g OGTT according to the American College of Obstetricians and Gynecologists supported by the American Diabetes Association...
- Are already on or intended to start intensive insulin treatment (at leased 2 injections of insulin per day) or wear an insulin pump.
- Are willing to wear a continuous glucose monitoring system.
You likely can't join if
- Individual with risk factors for:
- Placental insufficiency.
- Hypertension.
- Renal disease.
- Thrombophilia
- Rheumatologic disease.
See the full eligibility criteria
- Pregnant women with singleton pregnancies.
- Over 18 years old.
- Diagnosis of GDM- 3-h 100-g OGTT according to the American College of Obstetricians and Gynecologists supported by the American Diabetes Association, Or Diagnosis of type 1 or 2 diabetes before pregnancy, Or Diagnosis...
- Are already on or intended to start intensive insulin treatment (at leased 2 injections of insulin per day) or wear an insulin pump.
- Are willing to wear a continuous glucose monitoring system.
- BMI of 18.5-42 kg/m2 at the time of diagnosis.
- Individual with risk factors for:
- Placental insufficiency.
- Hypertension.
- Renal disease.
- Thrombophilia
- Rheumatologic disease.
- A history of preeclampsia, or fetal growth restriction (IUGR).
- Individuals with a history of preterm labor, or concomitant therapy with β-blockers or glucocorticoids.
- Individuals who smoke and/or consume any amount of alcohol during pregnancy.
The study team makes the final eligibility decision.
Where it's taking place
- Jerusalem, Israel
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years to 45 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Jerusalem, Israel. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.